Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults.

McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM.

Nicotine Tob Res. 2019 Oct 15. pii: ntz170. doi: 10.1093/ntr/ntz170. [Epub ahead of print]

PMID:
31612956
2.

Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.

Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ.

JAMA Pediatr. 2019 Oct 14. doi: 10.1001/jamapediatrics.2019.3553. [Epub ahead of print]

PMID:
31609433
3.

Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies.

Fadus MC, Squeglia LM, Valadez EA, Tomko RL, Bryant BE, Gray KM.

Curr Psychiatry Rep. 2019 Sep 14;21(10):96. doi: 10.1007/s11920-019-1086-0. Review.

PMID:
31522280
4.

Youth Substance Use: Introduction to the Journal of Child and Adolescent Psychopharmacology Special Issue.

Ivanov I, Gray KM.

J Child Adolesc Psychopharmacol. 2019 Aug;29(7):475-476. doi: 10.1089/cap.2019.29171.kvg. No abstract available.

PMID:
31483175
5.

Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration.

Adisetiyo V, Gray KM, Jensen JH, Helpern JA.

Neuroimage Clin. 2019 Aug 26;24:101993. doi: 10.1016/j.nicl.2019.101993. [Epub ahead of print]

6.

Assessment of inorganic contamination of private wells and demonstration of effective filter-based reduction: A pilot-study in Stokes County, North Carolina.

Tomlinson MS, Bommarito P, George A, Yelton S, Cable P, Coyte R, Karr J, Vengosh A, Gray KM, Fry RC.

Environ Res. 2019 Oct;177:108618. doi: 10.1016/j.envres.2019.108618. Epub 2019 Aug 2.

PMID:
31419714
7.

An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity.

Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM.

Addict Behav. 2019 Nov;98:106052. doi: 10.1016/j.addbeh.2019.106052. Epub 2019 Jul 15.

PMID:
31415971
8.

Image processing and analysis methods for the Adolescent Brain Cognitive Development Study.

Hagler DJ Jr, Hatton S, Cornejo MD, Makowski C, Fair DA, Dick AS, Sutherland MT, Casey BJ, Barch DM, Harms MP, Watts R, Bjork JM, Garavan HP, Hilmer L, Pung CJ, Sicat CS, Kuperman J, Bartsch H, Xue F, Heitzeg MM, Laird AR, Trinh TT, Gonzalez R, Tapert SF, Riedel MC, Squeglia LM, Hyde LW, Rosenberg MD, Earl EA, Howlett KD, Baker FC, Soules M, Diaz J, de Leon OR, Thompson WK, Neale MC, Herting M, Sowell ER, Alvarez RP, Hawes SW, Sanchez M, Bodurka J, Breslin FJ, Morris AS, Paulus MP, Simmons WK, Polimeni JR, van der Kouwe A, Nencka AS, Gray KM, Pierpaoli C, Matochik JA, Noronha A, Aklin WM, Conway K, Glantz M, Hoffman E, Little R, Lopez M, Pariyadath V, Weiss SR, Wolff-Hughes DL, DelCarmen-Wiggins R, Feldstein Ewing SW, Miranda-Dominguez O, Nagel BJ, Perrone AJ, Sturgeon DT, Goldstone A, Pfefferbaum A, Pohl KM, Prouty D, Uban K, Bookheimer SY, Dapretto M, Galvan A, Bagot K, Giedd J, Infante MA, Jacobus J, Patrick K, Shilling PD, Desikan R, Li Y, Sugrue L, Banich MT, Friedman N, Hewitt JK, Hopfer C, Sakai J, Tanabe J, Cottler LB, Nixon SJ, Chang L, Cloak C, Ernst T, Reeves G, Kennedy DN, Heeringa S, Peltier S, Schulenberg J, Sripada C, Zucker RA, Iacono WG, Luciana M, Calabro FJ, Clark DB, Lewis DA, Luna B, Schirda C, Brima T, Foxe JJ, Freedman EG, Mruzek DW, Mason MJ, Huber R, McGlade E, Prescot A, Renshaw PF, Yurgelun-Todd DA, Allgaier NA, Dumas JA, Ivanova M, Potter A, Florsheim P, Larson C, Lisdahl K, Charness ME, Fuemmeler B, Hettema JM, Maes HH, Steinberg J, Anokhin AP, Glaser P, Heath AC, Madden PA, Baskin-Sommers A, Constable RT, Grant SJ, Dowling GJ, Brown SA, Jernigan TL, Dale AM.

Neuroimage. 2019 Aug 12;202:116091. doi: 10.1016/j.neuroimage.2019.116091. [Epub ahead of print]

PMID:
31415884
9.

Characteristics and Care Outcomes Among Persons Living With Perinatally Acquired HIV Infection in the United States, 2015.

Gray KM, Wang X, Li J, Nesheim SR.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):17-23. doi: 10.1097/QAI.0000000000002091.

PMID:
31169773
10.

Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users.

Karoly HC, Schacht JP, Jacobus J, Meredith LR, Taylor CT, Tapert SF, Gray KM, Squeglia LM.

Drug Alcohol Depend. 2019 Jul 1;200:145-152. doi: 10.1016/j.drugalcdep.2019.04.007. Epub 2019 May 14.

PMID:
31132681
11.

Pharmacological Treatment of Youth Substance Use Disorders.

Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM.

J Child Adolesc Psychopharmacol. 2019 Aug;29(7):559-572. doi: 10.1089/cap.2019.0009. Epub 2019 Apr 22.

PMID:
31009234
12.

Quantitative Phenotyping of Cell-Cell Junctions to Evaluate ZO-1 Presentation in Brain Endothelial Cells.

Gray KM, Katz DB, Brown EG, Stroka KM.

Ann Biomed Eng. 2019 Jul;47(7):1675-1687. doi: 10.1007/s10439-019-02266-5. Epub 2019 Apr 15.

PMID:
30993538
13.

Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults.

Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM.

Drug Alcohol Depend. 2019 May 1;198:105-111. doi: 10.1016/j.drugalcdep.2019.01.041. Epub 2019 Mar 14.

PMID:
30901744
14.

Methods to reduce the incidence of false negative trial results in substance use treatment research.

Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM.

Curr Opin Psychol. 2019 Jan 28;30:35-41. doi: 10.1016/j.copsyc.2019.01.009. [Epub ahead of print] Review.

PMID:
30798020
15.

Composition of the Survival Motor Neuron (SMN) Complex in Drosophila melanogaster.

Matera AG, Raimer AC, Schmidt CA, Kelly JA, Droby GN, Baillat D, Ten Have S, Lamond AI, Wagner EJ, Gray KM.

G3 (Bethesda). 2019 Feb 7;9(2):491-503. doi: 10.1534/g3.118.200874.

16.

Iatrogenic emergency medicine procedure complications and associated trouble-shooting strategies.

Ahmed RA, Hughes PG, Wong AH, Gray KM, Ballas D, Khobrani A, Selley RD, McQuown C.

Int J Health Care Qual Assur. 2018 Oct 8;31(8):935-949. doi: 10.1108/IJHCQA-08-2017-0157.

PMID:
30415624
17.

Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers.

Tomko RL, Saladin ME, Baker NL, McClure EA, Carpenter MJ, Ramakrishnan VR, Heckman BW, Wray JM, Foster KT, Tiffany ST, Metts CL, Gray KM.

Nicotine Tob Res. 2018 Oct 26. doi: 10.1093/ntr/nty234. [Epub ahead of print]

PMID:
30371887
18.

Corrigendum to The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine Addictive Behaviors 85 (2018) 26-30.

Tomko RL, Gilmore AK, Gray KM.

Addict Behav. 2019 Feb;89:263. doi: 10.1016/j.addbeh.2018.09.023. Epub 2018 Sep 27. No abstract available.

PMID:
30268706
19.

Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.

Nesheim SR, FitzHarris LF, Lampe MA, Gray KM.

Public Health Rep. 2018 Nov;133(6):637-643. doi: 10.1177/0033354918800466. Epub 2018 Sep 28.

PMID:
30265616
20.

Investigating a novel fMRI cannabis cue reactivity task in youth.

Karoly HC, Schacht JP, Meredith LR, Jacobus J, Tapert SF, Gray KM, Squeglia LM.

Addict Behav. 2019 Feb;89:20-28. doi: 10.1016/j.addbeh.2018.09.015. Epub 2018 Sep 11.

PMID:
30243035
21.

Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.

McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM.

Drug Alcohol Depend. 2018 Nov 1;192:59-66. doi: 10.1016/j.drugalcdep.2018.07.018. Epub 2018 Aug 25.

22.

N-acetylcysteine: A potential treatment for substance use disorders.

Tomko RL, Jones JL, Gilmore AK, Brady KT, Back SE, Gray KM.

Curr Psychiatr. 2018 Jun;17(6):30-36, 41-42, 55. No abstract available.

23.

Behavioural phenotypes: working towards translational research through research partnerships.

Adams D, Heussler H, Gray KM.

J Intellect Disabil Res. 2018 Aug;62(8):661-663. doi: 10.1111/jir.12513. No abstract available.

PMID:
30003626
24.

Impact of cannabis legalization on treatment and research priorities for cannabis use disorder.

Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL.

Int Rev Psychiatry. 2018 Jun;30(3):216-225. doi: 10.1080/09540261.2018.1465398. Epub 2018 Jun 29. Review.

25.

The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.

Tomko RL, Gilmore AK, Gray KM.

Addict Behav. 2018 Oct;85:26-30. doi: 10.1016/j.addbeh.2018.05.014. Epub 2018 May 21. Erratum in: Addict Behav. 2019 Feb;89:263.

26.

Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers.

McClure EA, Tomko RL, Carpenter MJ, Treiber FA, Gray KM.

Am J Drug Alcohol Abuse. 2018;44(5):561-570. doi: 10.1080/00952990.2018.1467431. Epub 2018 May 8.

27.

Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.

Baker NL, Gray KM, Sherman BJ, Morella K, Sahlem GL, Wagner AM, McRae-Clark AL.

Drug Alcohol Depend. 2018 Jun 1;187:270-277. doi: 10.1016/j.drugalcdep.2018.03.017. Epub 2018 Apr 16.

28.

A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users.

Jacobus J, Taylor CT, Gray KM, Meredith LR, Porter AM, Li I, Castro N, Squeglia LM.

Drug Alcohol Depend. 2018 Jun 1;187:195-204. doi: 10.1016/j.drugalcdep.2018.03.007. Epub 2018 Apr 11.

29.

From Content Knowledge to Community Change: A Review of Representations of Environmental Health Literacy.

Gray KM.

Int J Environ Res Public Health. 2018 Mar 7;15(3). pii: E466. doi: 10.3390/ijerph15030466. Review.

30.

Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection.

Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA.

Am J Drug Alcohol Abuse. 2019;45(1):26-41. doi: 10.1080/00952990.2018.1437445. Epub 2018 Mar 7.

PMID:
29513609
31.

Caregiver Mental Health, Parenting Practices, and Perceptions of Child Attachment in Children with Autism Spectrum Disorder.

Teague SJ, Newman LK, Tonge BJ, Gray KM; MHYPeDD team.

J Autism Dev Disord. 2018 Aug;48(8):2642-2652. doi: 10.1007/s10803-018-3517-x.

PMID:
29500757
32.

The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.

Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM.

Drug Alcohol Depend. 2018 Apr 1;185:17-22. doi: 10.1016/j.drugalcdep.2017.12.005. Epub 2018 Feb 1.

33.

THC potency needs to be tracked.

Gray KM.

Am J Addict. 2018 Jan;27(1):46. doi: 10.1111/ajad.12673. No abstract available.

PMID:
29283485
34.

Almond or Mahaleb? Orthogonal Allergen Analysis During a Live Incident Investigation by ELISA, Molecular Biology, and Protein Mass Spectrometry.

Walker MJ, Burns M, Quaglia M, Nixon G, Hopley CJ, Gray KM, Moore V, Singh M, Cowen S.

J AOAC Int. 2018 Jan 1;101(1):162-169. doi: 10.5740/jaoacint.17-0405. Epub 2017 Dec 5.

PMID:
29202918
35.

Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCFSlmb degron.

Gray KM, Kaifer KA, Baillat D, Wen Y, Bonacci TR, Ebert AD, Raimer AC, Spring AM, Have ST, Glascock JJ, Gupta K, Van Duyne GD, Emanuele MJ, Lamond AI, Wagner EJ, Lorson CL, Matera AG.

Mol Biol Cell. 2018 Jan 15;29(2):96-110. doi: 10.1091/mbc.E17-11-0627. Epub 2017 Nov 22.

36.

Parenting and family adjustment scales (PAFAS): validation of a brief parent-report measure for use with families who have a child with a developmental disability.

Mazzucchelli TG, Hodges J, Kane RT, Sofronoff K, Sanders MR, Einfeld S, Tonge B, Gray KM; MHYPEDD Project Team.

Res Dev Disabil. 2018 Jan;72:140-151. doi: 10.1016/j.ridd.2017.10.011. Epub 2017 Nov 14.

PMID:
29145013
37.

Troponin Limit of Detection Plus Cardiac Risk Stratification Scores to Rule Out Acute Myocardial Infarction and 30-Day Major Adverse Cardiac Events in ED Patients.

Datlow MD, Gray KM, Watts A, Diercks DB, Mumma BE.

Crit Pathw Cardiol. 2017 Dec;16(4):142-146. doi: 10.1097/HPC.0000000000000129.

38.

A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.

Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, Froeliger B, Cummings KM.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1795-1803. doi: 10.1158/1055-9965.EPI-17-0460. Epub 2017 Nov 10.

39.

Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.

Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM.

Drug Alcohol Depend. 2018 Jan 1;182:1-7. doi: 10.1016/j.drugalcdep.2017.09.035. Epub 2017 Nov 2.

40.

Country of Birth of Children With Diagnosed HIV Infection in the United States, 2008-2014.

Nesheim SR, Linley L, Gray KM, Zhang T, Shi J, Lampe MA, FitzHarris LF.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):23-30. doi: 10.1097/QAI.0000000000001572.

41.

Concurrence of the strengths and difficulties questionnaire and developmental behaviour checklist among children with an intellectual disability.

Rice LJ, Emerson E, Gray KM, Howlin P, Tonge BJ, Warner GL, Einfeld SL.

J Intellect Disabil Res. 2018 Feb;62(2):150-155. doi: 10.1111/jir.12426. Epub 2017 Oct 5.

PMID:
28980362
42.

Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles.

Patel DB, Gray KM, Santharam Y, Lamichhane TN, Stroka KM, Jay SM.

Bioeng Transl Med. 2017 Jun 26;2(2):170-179. doi: 10.1002/btm2.10065. eCollection 2017 Jun.

43.

Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM.

J Subst Abuse Treat. 2017 Oct;81:53-58. doi: 10.1016/j.jsat.2017.07.012. Epub 2017 Jul 29.

44.

Research Review: What have we learned about adolescent substance use?

Gray KM, Squeglia LM.

J Child Psychol Psychiatry. 2018 Jun;59(6):618-627. doi: 10.1111/jcpp.12783. Epub 2017 Jul 17. Review.

45.

Systematic Review and Meta-analysis of Parent Group Interventions for Primary School Children Aged 4-12 Years with Externalizing and/or Internalizing Problems.

Buchanan-Pascall S, Gray KM, Gordon M, Melvin GA.

Child Psychiatry Hum Dev. 2018 Apr;49(2):244-267. doi: 10.1007/s10578-017-0745-9.

PMID:
28699101
46.

Vascular endothelial cell mechanosensing: New insights gained from biomimetic microfluidic models.

Gray KM, Stroka KM.

Semin Cell Dev Biol. 2017 Nov;71:106-117. doi: 10.1016/j.semcdb.2017.06.002. Epub 2017 Jun 17. Review.

PMID:
28633977
47.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

48.

Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.

McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM.

Drug Alcohol Depend. 2017 Jul 1;176:14-20. doi: 10.1016/j.drugalcdep.2017.02.024. Epub 2017 May 10.

49.

Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability.

Froeliger B, McConnell PA, Bell S, Sweitzer M, Kozink RV, Eichberg C, Hallyburton M, Kaiser N, Gray KM, McClernon FJ.

JAMA Psychiatry. 2017 Apr 1;74(4):379-386. doi: 10.1001/jamapsychiatry.2017.0017.

50.

Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM.

Am J Addict. 2017 Mar;26(2):136-144. doi: 10.1111/ajad.12503. Epub 2017 Feb 2.

Supplemental Content

Support Center